Clinical Trial Update: Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy [Phase 1, Phase 2]

View source ↗

Summary

A phased pharmacokinetic study of the Ledipasvir/Sofosbuvir combination in children with chronic hepatitis C and concurrent hematologic malignancies has been co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

Sponsor: Ain Shams University | Conditions: Hepatitis C, Chronic, Hematologic Malignancy | Phase 1, Phase 2 | Status: COMPLETED